Q1 2025 Outset Medical Inc Earnings Call Transcript
Key Points
- Outset Medical Inc (OM) reported a 6% revenue growth in the first quarter of 2025 compared to the same period last year, reaching $29.8 million.
- Console revenue saw a significant 23% sequential growth, indicating strong demand and successful sales transformation.
- Recurring revenue from Tablo treatments and services grew by 20% year-over-year, highlighting the consistent utilization of their products.
- Non-GAAP gross margin improved to 37.6%, with potential to reach 50% as operational efficiencies continue to be realized.
- The company successfully reduced operating expenses by 30% year-over-year, contributing to the lowest non-GAAP operating loss since their IPO.
- Despite the positive quarter, Outset Medical Inc (OM) maintained a conservative guidance approach, indicating potential caution about future quarters.
- The company is still facing challenges with the absorption of manufacturing overhead, which affected gross margin by approximately 230 basis points.
- There is a noted dependency on the continued success of the sales transformation, which is expected to be fully complete by the first half of 2025.
- The healthcare environment remains dynamic with potential risks from federal funding cuts, although no immediate impact has been observed.
- Outset Medical Inc (OM) has not adjusted its guidance despite a strong quarter, suggesting uncertainty or potential challenges in maintaining momentum.
Good day, and thank you for standing by. Welcome to the Outset Medical first quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Jim Mazzola, Head of Investor Relations. Please go ahead.
Okay. Thanks, Victor. Good afternoon, everyone, and welcome to our first quarter 2025 earnings call. Here with me today are Leslie Trigg, Chair and Chief Executive Officer; and Nabeel Ahmed, Chief Financial Officer. We issued a news release after the close of market today, which can be found on the investor pages of outsetmedical.com.
And this call is being recorded and will be archived on the Investors section of our website. It's our intent that all forward-looking statements made during today's call will be protected under the Private Securities Litigation Reform Act of 1995. These statements relate to expectations or predictions of future events, are based
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
